Pomanda estimates the enterprise value of SOLITAIRE PHARMA LIMITED at £7.5k based on a Turnover of £15k and 0.5x industry multiple (adjusted for size and gross margin).
solitaire pharma limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of SOLITAIRE PHARMA LIMITED at £0 based on an EBITDA of £-99 and a 3.55x industry multiple (adjusted for size and gross margin).
solitaire pharma limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of SOLITAIRE PHARMA LIMITED at £0 based on Net Assets of £-2.2k and 2.37x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Solitaire Pharma LimitedOverview
Solitaire Pharma Limited is a dissolved company that was located in london, W1H 1JU with a Companies House number of 05813832. It operated in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in May 2006, it's largest shareholder was
peyman mahgerefteh
with a 67% stake. The last turnover for Solitaire Pharma Limited was estimated at £15k.
Pomanda's financial health check has awarded Solitaire Pharma Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 5 areas for improvement. Company Health Check FAQs
Health Rating1out of 5
1 Strong
2 Regular
5 Weak
Size
annual sales of £15k, make it smaller than the average company (£2.5m)
£15k - Solitaire Pharma Limited
£2.5m - Industry AVG
Growth
3 year (CAGR) sales growth of -52%, show it is growing at a slower rate (4.4%)
-52% - Solitaire Pharma Limited
4.4% - Industry AVG
Production
with a gross margin of 38.1%, this company has a comparable cost of product (38.1%)
38.1% - Solitaire Pharma Limited
38.1% - Industry AVG
Profitability
an operating margin of -0.7% make it less profitable than the average company (5.5%)
-0.7% - Solitaire Pharma Limited
5.5% - Industry AVG
Employees
with 1 employees, this is below the industry average (21)
1 - Solitaire Pharma Limited
21 - Industry AVG
Pay Structure
on an average salary of £42.2k, the company has an equivalent pay structure (£42.2k)
£42.2k - Solitaire Pharma Limited
£42.2k - Industry AVG
Efficiency
resulting in sales per employee of £15k, this is less efficient (£135.5k)
£15k - Solitaire Pharma Limited
£135.5k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Solitaire Pharma Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 86 days, this is slower than average (33 days)
86 days - Solitaire Pharma Limited
33 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Solitaire Pharma Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Solitaire Pharma Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Solitaire Pharma Limited
- - Industry AVG
SOLITAIRE PHARMA LIMITED financials
EXPORT
Solitaire Pharma Limited's latest turnover from May 2020 is estimated at £15 thousand and the company has net assets of -£2.2 thousand. According to their latest financial statements, we estimate that Solitaire Pharma Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
May 2020
May 2019
May 2018
May 2017
May 2016
May 2015
May 2014
May 2013
May 2012
May 2011
May 2010
Turnover
15,029
216,308
214,890
133,338
233,870
214,058
211,213
217,949
223,035
147,812
26,509
Other Income Or Grants
Cost Of Sales
9,309
135,375
134,477
81,929
144,593
135,444
135,625
139,833
139,592
89,757
15,731
Gross Profit
5,720
80,934
80,412
51,410
89,276
78,614
75,587
78,116
83,443
58,055
10,778
Admin Expenses
5,819
80,935
81,624
51,926
89,862
79,304
74,258
79,619
83,566
57,077
9,907
Operating Profit
-99
-1
-1,212
-516
-586
-690
1,329
-1,503
-123
978
871
Interest Payable
Interest Receivable
1
1
1
1
5
6
1
Pre-Tax Profit
-99
-1
-1,212
-516
-586
-690
1,329
-1,502
-118
984
872
Tax
-279
-256
-244
Profit After Tax
-99
-1
-1,212
-516
-586
-690
1,050
-1,502
-118
728
628
Dividends Paid
Retained Profit
-99
-1
-1,212
-516
-586
-690
1,050
-1,502
-118
728
628
Employee Costs
42,216
82,651
78,228
75,724
76,051
75,336
75,405
73,560
73,795
72,244
35,801
Number Of Employees
1
2
2
2
2
2
2
2
2
2
1
EBITDA*
-99
-1
-1,212
-497
-510
-639
1,398
-1,412
-1
1,140
1,087
* Earnings Before Interest, Tax, Depreciation and Amortisation
May 2020
May 2019
May 2018
May 2017
May 2016
May 2015
May 2014
May 2013
May 2012
May 2011
May 2010
Tangible Assets
43
58
77
153
204
273
364
486
648
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
43
58
77
153
204
273
364
486
648
Stock & work in progress
2,942
4,436
Trade Debtors
27,605
27,606
27,013
27,013
27,013
27,013
27,083
29,160
20,698
2,164
Group Debtors
Misc Debtors
Cash
107
100
100
100
111
103
1,941
299
misc current assets
total current assets
27,605
27,606
27,120
27,113
27,113
27,113
27,194
29,263
25,581
6,899
total assets
27,605
27,649
27,178
27,190
27,266
27,317
27,467
29,627
26,067
7,547
Bank overdraft
9
Bank loan
Trade Creditors
2,218
29,824
29,867
613
27,070
26,431
27,631
28,289
24,611
6,819
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities
27,471
27,571
total current liabilities
2,218
29,824
29,867
28,084
27,580
27,070
26,431
27,631
28,289
24,611
6,819
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
2,218
29,824
29,867
28,084
27,580
27,070
26,431
27,631
28,289
24,611
6,819
net assets
-2,218
-2,219
-2,218
-906
-390
196
886
-164
1,338
1,456
728
total shareholders funds
-2,218
-2,219
-2,218
-906
-390
196
886
-164
1,338
1,456
728
May 2020
May 2019
May 2018
May 2017
May 2016
May 2015
May 2014
May 2013
May 2012
May 2011
May 2010
Operating Activities
Operating Profit
-99
-1
-1,212
-516
-586
-690
1,329
-1,503
-123
978
871
Depreciation
19
76
51
69
91
122
162
216
Amortisation
Tax
-279
-256
-244
Stock
-2,942
-1,494
4,436
Debtors
-27,605
-1
593
-70
-2,077
8,462
18,534
2,164
Creditors
-27,606
-43
29,254
613
-27,070
639
-1,200
-658
3,678
17,792
6,819
Accruals and Deferred Income
-27,471
-100
27,571
Deferred Taxes & Provisions
Cash flow from operations
-100
-43
-22
16
-9
-11
7
-1,843
1,636
1,062
Investing Activities
capital expenditure
43
15
-864
Change in Investments
cash flow from investments
43
15
-864
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
100
-100
100
interest
1
1
1
1
5
6
1
cash flow from financing
100
-100
1
1
1
1
5
6
101
cash and cash equivalents
cash
-107
7
-11
8
-1,838
1,642
299
overdraft
-9
9
change in cash
-107
16
-9
-11
8
-1,838
1,642
299
solitaire pharma limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for solitaire pharma limited. Get real-time insights into solitaire pharma limited's credit score, group structure and payment trends.
Perform a competitor analysis for solitaire pharma limited by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other undefined companies, companies in W1H area or any other competitors across 12 key performance metrics.
solitaire pharma limited Ownership
SOLITAIRE PHARMA LIMITED group structure
Solitaire Pharma Limited has no subsidiary companies.
Ultimate parent company
SOLITAIRE PHARMA LIMITED
05813832
SOLITAIRE PHARMA LIMITED Shareholders
The largest shareholders in Solitaire Pharma Limited include Peyman Mahgerefteh and Asaad Shavila.
peyman mahgerefteh
67%
asaad shavila
33%
solitaire pharma limited directors
Solitaire Pharma Limited currently has 1 director, Mr Peyman Mahgerefteh serving since Feb 2015.
82990 - Other business support service activities n.e.c.
incorporation date
May 2006
age
19
incorporated
UK
ultimate parent company
None
accounts
Total Exemption Full
last accounts submitted
May 2020
previous names
N/A
accountant
-
auditor
-
address
46 crawford street, london, W1H 1JU
Bank
-
Legal Advisor
-
solitaire pharma limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to solitaire pharma limited.
solitaire pharma limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SOLITAIRE PHARMA LIMITED. This can take several minutes, an email will notify you when this has completed.
solitaire pharma limitedCompanies House Filings - See Documents
